8.50
0.03 (0.35%)
| Penutupan Terdahulu | 8.47 |
| Buka | 8.49 |
| Jumlah Dagangan | 3,144,131 |
| Purata Dagangan (3B) | 4,029,720 |
| Modal Pasaran | 790,899,520 |
| Harga / Jualan (P/S) | 3.61 |
| Harga / Buku (P/B) | 6.58 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 21 Mar 2025 |
| Margin Operasi (TTM) | -43,073.68% |
| EPS Cair (TTM) | -0.990 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 1,325.00% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 0.97% |
| Nisbah Semasa (MRQ) | 5.70 |
| Aliran Tunai Operasi (OCF TTM) | -74.98 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -44.05 M |
| Pulangan Atas Aset (ROA TTM) | -33.64% |
| Pulangan Atas Ekuiti (ROE TTM) | -56.17% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menurun | Menurun |
| Biotechnology (Global) | Menurun | Menurun | |
| Stok | Chimerix, Inc. | Menaik | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | 1.5 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -0.5 |
| Purata Bergerak Teknikal | -5.0 |
| Osilator Teknikal | 0.5 |
| Purata | -0.88 |
|
Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through revenue related to non-refundable upfront fees, royalties and milestone payments earned under license agreements, also by royalty revenue related to sales of TEMBEXA made by Emergent after the Asset Sale. The company operates only in one business segment namely pharmaceuticals. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 1.73% |
| % Dimiliki oleh Institusi | 56.44% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 11.00 (HC Wainwright & Co., 29.41%) | Pegang |
| Median | 8.55 (0.59%) | |
| Rendah | 8.50 (Jefferies, 0.00%) | Pegang |
| Purata | 9.35 (10.00%) | |
| Jumlah | 3 Pegang | |
| Harga Purata @ Panggilan | 8.45 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Jones Trading | 06 Mar 2025 | 8.55 (0.59%) | Pegang | 8.43 |
| HC Wainwright & Co. | 05 Mar 2025 | 11.00 (29.41%) | Pegang | 8.46 |
| Jefferies | 05 Mar 2025 | 8.50 (0.00%) | Pegang | 8.46 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |